Yunkang Group Limited (HK:2325) has released an update.
Yunkang Group Limited has issued a profit warning, expecting to report a net loss of RMB 100 to 140 million for the first half of 2024 in contrast to a net profit last year, attributed to economic challenges and increased competition in the medical service market. Despite the short-term setbacks, the Group maintains a positive outlook for the healthcare industry’s long-term growth and is focusing on innovation and lean operations to navigate the current difficulties. Shareholders and potential investors are cautioned to consider that the financial data is preliminary and unaudited, with the official interim results due to be published in August 2024.
For further insights into HK:2325 stock, check out TipRanks’ Stock Analysis page.